T1	Participants 44 77	antipsychotic-induced weight gain
T2	Participants 127 236	Weight gain is common for individuals with serious mental illness (SMI) receiving antipsychotic drug therapy.
T3	Participants 387 403	SMI populations.
T4	Participants 521 554	30 individuals (BMI â‰¥ 28 kg/m(2))
T5	Participants 1331 1373	patients taking antipsychotic medications;
T6	Participants 1374 1469	financial reimbursement for behavioral change may be particularly effective in this population.
